Literature DB >> 6092713

Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease.

A Simmons, A A Nash.   

Abstract

During the development of a zosteriform rash, which occurs after flank inoculation of BALB/c mice with herpes simplex virus, clinically normal skin becomes infected via nerve endings. This is analogous to the final step in the development of a recrudescent lesion, which may occur after reactivation of latent virus. Therefore, the zosteriform reaction has potential as a model with which to study the modification of such a recrudescent infection by immune processes. Using an adoptive transfer system, we confirmed that immune lymph node cells are potent in accelerating the clearance of virus from the primary site of replication (the inoculation site). This effect was T cell dependent. However, if injection of the same cell population was delayed until ganglionic infection was established, the appearance of the zosteriform rash was not prevented, and the virus titer recovered from the lower flank was not reduced. Immunoperoxidase studies showed that virus is at first highly localized to the epidermis after it emerges from nerves. As determined by conventional histology, little cellular infiltration was seen until clinical lesions were apparent. These observations indicate that recrudescent lesions appear in the presence of cell populations normally associated with rapid virus clearance; cellular immune mechanisms may be rendered ineffective owing to the lack of recruitment to the site of recrudescence until tissue breakdown instigates an inflammatory response.

Entities:  

Mesh:

Year:  1984        PMID: 6092713      PMCID: PMC254600     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.

Authors:  J E Oakes
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells.

Authors:  K Pfizenmaier; A Starzinski-Powitz; M Röllinghoff; D Falks; H Wagner
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

3.  Electron microscopy of zosteriform herpes simplex infection in the mouse.

Authors:  S H Dillard; W J Cheatham; H L Moses
Journal:  Lab Invest       Date:  1972-04       Impact factor: 5.662

4.  Depression of acquired resistance against herpes simplex virus infection in neonatally thymectomized mice.

Authors:  R Mori; T Tasaki; G Kimura; K Takeya
Journal:  Arch Gesamte Virusforsch       Date:  1967

5.  Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.

Authors:  B Rager-Zisman; A C Allison
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

6.  Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.

Authors:  T J Hill; H J Field; W A Blyth
Journal:  J Gen Virol       Date:  1975-09       Impact factor: 3.891

7.  The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.

Authors:  S L Spruance; J C Overall; E R Kern; G G Krueger; V Pliam; W Miller
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

8.  Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus types 1 or 2.

Authors:  K K Sethi; H Brandis
Journal:  Z Immunitatsforsch Immunobiol       Date:  1977-07

9.  Host defense mechanisms against Herpes simplex virus. I. Control of infection in vitro by senstized spleen cells and antibody.

Authors:  F A Ennis
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

10.  Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

View more
  69 in total

1.  Cell surface expression of H2 antigens on primary sensory neurons in response to acute but not latent herpes simplex virus infection in vivo.

Authors:  R A Pereira; A Simmons
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease.

Authors:  C E Saldanha; J Lubinski; C Martin; T Nagashunmugam; L Wang; H van Der Keyl; R Tal-Singer; H M Friedman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Immunization with combined HSV-2 glycoproteins B2 : D2 gene DNAs: protection against lethal intravaginal challenges in mice.

Authors:  Hyung Hoan Lee; Soung Chul Cha; Dong June Jang; Jun Keun Lee; Dong Wan Choo; Young Sik Kim; Hong Sun Uh; Soo Young Kim
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

4.  Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation.

Authors:  Laura K Mackay; Angus T Stock; Joel Z Ma; Claerwen M Jones; Stephen J Kent; Scott N Mueller; William R Heath; Francis R Carbone; Thomas Gebhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

5.  Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1.

Authors:  P G Speck; A Simmons
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine.

Authors:  M Erturk; T J Hill; C Shimeld; R Jennings
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells.

Authors:  Sammy Bedoui; Paul G Whitney; Jason Waithman; Liv Eidsmo; Linda Wakim; Irina Caminschi; Rhys S Allan; Magdalena Wojtasiak; Ken Shortman; Francis R Carbone; Andrew G Brooks; William R Heath
Journal:  Nat Immunol       Date:  2009-04-06       Impact factor: 25.606

8.  Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus.

Authors:  Thomas Gebhardt; Linda M Wakim; Liv Eidsmo; Patrick C Reading; William R Heath; Francis R Carbone
Journal:  Nat Immunol       Date:  2009-03-22       Impact factor: 25.606

9.  Pathologic studies and comparison of the virulence of herpes simplex virus type 2 from Okinawa, Japan and Chiang Mai, Thailand.

Authors:  K Sunagawa; W Sirirungsi; I Nakazato; T Hirayasu; T Iwamasa
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

10.  In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.

Authors:  T Nagashunmugam; J Lubinski; L Wang; L T Goldstein; B S Weeks; P Sundaresan; E H Kang; G Dubin; H M Friedman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.